"Nonopioid Pain Management | AHA " American Hospital Association, 2018, www.aha.org/bibliographylink-page/2018-09-28-nonopioid-pain-management. Accessed 13 Nov. 2019.
"Overdose Death Maps " CDC, 13 Aug. 2019, www.cdc.gov/drugoverdose/data/prescribing/overdosedeath-maps.html.
Wansink, Brian, et al. "An Anchoring and Adjustment Model of Purchase Quantity Decisions." Journal of Marketing Research, vol. 35, no. 1, Feb. 1998, pp. 71-81, 10.1177/002224379803500108.
Amir R, Leiba R, Eisenberg E Anchoring the Numeric Pain Scale Changes Pain Intensity Reports in Patients With Chronic But Not With Acute Pain. Pain Pract. 2019 Mar;19(3):283-288. doi: 10.1111/papr.12738. Epub 2018 Nov 20.
Brewer NT, Chapman GB, Schwartz JA, Bergus GR The influence of irrelevant anchors on the judgments and choices of doctors and patients. Med Decis Making. 2007 Mar-Apr;27(2):203-11.
Compton WM, Jones CM, Baldwin GT Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. N Engl J Med. 2016 Jan 14;374(2):154-63. doi: 10.1056/NEJMra1508490. Review.
Liang, Hanchao, et al "Bounded Rationality, Anchoring-and-Adjustment Sentiment, and Asset Pricing." The North American Journal of Economics and Finance, vol. 40, Apr. 2017, pp. 85-102, 10.1016/j.najef.2017.02.001. Accessed 13 Nov. 2019.
Marco CA, Kanitz W, Jolly M Pain scores among emergency department (ED) patients: comparison by ED diagnosis. J Emerg Med. 2013 Jan;44(1):46-52. doi: 10.1016/j.jemermed.2012.05.002. Epub 2012 Jul 13.
Marco CA, Nagel J, Klink E, Baehren D Factors associated with self-reported pain scores among ED patients. Am J Emerg Med. 2012 Feb;30(2):331-7. doi: 10.1016/j.ajem.2010.12.015. Epub 2011 Mar 1.
Meisel ZF, Lupulescu-Mann N, Charlesworth CJ, Kim H, Sun BC Conversion to Persistent or High-Risk Opioid Use After a New Prescription From the Emergency Department: Evidence From Washington Medicaid Beneficiaries. Ann Emerg Med. 2019 Nov;74(5):611-621. doi: 10.1016/j.annemergmed.2019.04.007. Epub 2019 Jun 20.
Northcraft, Gregory B, and Margaret A Neale "Experts, Amateurs, and Real Estate: An Anchoring-andAdjustment Perspective on Property Pricing Decisions." Organizational Behavior and Human Decision Processes, vol. 39, no. 1, 1987, pp. 84-97, 10.1016/0749-5978(87)90046-x.
Riva P, Rusconi P, Montali L, Cherubini P The influence of anchoring on pain judgment. J Pain Symptom Manage. 2011 Aug;42(2):265-77. doi: 10.1016/j.jpainsymman.2010.10.264. Epub 2011 Mar 12.
Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018 Jan 4;67(5152):1419-1427. doi: 10.15585/mmwr.mm675152e1.
Tversky A, Kahneman D Judgment under Uncertainty: Heuristics and Biases. Science. 1974 Sep 27;185(4157):1124-31.
Yadav, Manjit S "How Buyers Evaluate Product Bundles: A Model of Anchoring and Adjustment." Journal of Consumer Research, vol. 21, no. 2, Sept. 1994, p. 342, 10.1086/209402.
Anchoring Patients Pain Scores in the Emergency Department
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
